473 related articles for article (PubMed ID: 12969225)
41. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
[TBL] [Abstract][Full Text] [Related]
42. p53 and Ki 67 expression in preneoplastic and neoplastic lesions of the oral mucosa.
Girod SC; Krueger G; Pape HD
Int J Oral Maxillofac Surg; 1993 Oct; 22(5):285-8. PubMed ID: 8245568
[TBL] [Abstract][Full Text] [Related]
43. Multivariate analyses of Ki-67, cytokeratin 13 and cytokeratin 17 in diagnosis and prognosis of oral precancerous lesions.
Yagyuu T; Obayashi C; Ueyama Y; Takano M; Tanaka Y; Kawaguchi M; Takeda M; Kasai T; Kirita T
J Oral Pathol Med; 2015 Aug; 44(7):523-31. PubMed ID: 25243470
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma.
Kiyosue T; Kawano S; Matsubara R; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Clin Oncol; 2013 Feb; 18(1):154-63. PubMed ID: 22170235
[TBL] [Abstract][Full Text] [Related]
45. Syndecan-1: a new prognostic marker in laryngeal cancer.
Pulkkinen JO; Penttinen M; Jalkanen M; Klemi P; Grénman R
Acta Otolaryngol; 1997 Mar; 117(2):312-5. PubMed ID: 9105473
[TBL] [Abstract][Full Text] [Related]
46. Changes in apoptosis and mitotic index, p53 and Ki67 expression in various types of oral leukoplakia.
Kövesi G; Szende B
Oncology; 2003; 65(4):331-6. PubMed ID: 14707453
[TBL] [Abstract][Full Text] [Related]
47. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
Gao Y; Guo ZL; Luo HY; Wang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
[TBL] [Abstract][Full Text] [Related]
48. Midkine expression in oral squamous cell carcinoma and leukoplakia.
Jham BC; Costa NL; Silva JM; de Miranda AC; Oliveira JC; Silva TA; Batista AC
J Oral Pathol Med; 2012 Jan; 41(1):21-6. PubMed ID: 21595751
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathological features and immunohistochemical expression of p53, Ki-67, Mcm-2 and Mcm-5 in proliferative verrucous leukoplakia.
Gouvêa AF; Vargas PA; Coletta RD; Jorge J; Lopes MA
J Oral Pathol Med; 2010 Jul; 39(6):447-52. PubMed ID: 20412398
[TBL] [Abstract][Full Text] [Related]
50. Immunoexpression of tenascin as a predictor of the malignancy potential of oral leukoplakia associated with a tobacco habit.
Mane DR; Bhat K; Kale AD; Hallikerimath S
Biotech Histochem; 2015; 90(7):544-51. PubMed ID: 25839195
[TBL] [Abstract][Full Text] [Related]
51. Epithelial growth fraction and expression of p53 tumour suppressor gene in oral submucous fibrosis.
Cox SC; Walker DM
Aust Dent J; 1996 Apr; 41(2):91-6. PubMed ID: 8670041
[TBL] [Abstract][Full Text] [Related]
52. Association between epithelial-mesenchymal transition markers, proliferative index, and oral epithelial dysplasia: an immunohistochemical study.
Miguel AFP; Poletto DAG; Embaló B; Rivero ERC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jun; 135(6):904-913. PubMed ID: 37248101
[TBL] [Abstract][Full Text] [Related]
53. [Immunohistochemical expression of p53 protein in squamous epithelial carcinomas and normal and dysplastic epithelium of the mouth cavity].
Piffkó J; Bánkfalvi A
Mund Kiefer Gesichtschir; 1997 Mar; 1(2):104-7. PubMed ID: 9410611
[TBL] [Abstract][Full Text] [Related]
54. Assessment of laminin-5 in oral dysplasia and squamous cell carcinoma.
Rani V; McCullough M; Chandu A
J Oral Maxillofac Surg; 2013 Nov; 71(11):1873-9. PubMed ID: 23891017
[TBL] [Abstract][Full Text] [Related]
55. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
[TBL] [Abstract][Full Text] [Related]
56. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
58. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia.
D'souza B; Nayak R; Kotrashetti VS
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448
[TBL] [Abstract][Full Text] [Related]
59. Expression of apoptotic signaling proteins in leukoplakia and oral lichen planus: quantitative and topographical studies.
Tanda N; Mori S; Saito K; Ikawa K; Sakamoto S
J Oral Pathol Med; 2000 Sep; 29(8):385-93. PubMed ID: 10972347
[TBL] [Abstract][Full Text] [Related]
60. DEC1: a potential biomarker of malignant transformation in oral leukoplakia.
Mao T; Xiong H; Hu X; Hu Y; Wang C; Yang L; Huang D; Xia K; Su T
Braz Oral Res; 2020; 34():e052. PubMed ID: 32578762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
